Track EZZ Life Science Holdings Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

EZZ Life Science Holdings Limited EZZ.AX · Stock Open EZZ Life Science Holdings Limited in new tab

0.3100 AUD
P/E
5.83
EPS
-0.11
Yield
12.12%
Safety Score
2
P/B
0.63
ROE
-20.25
Beta
1.14
Loading chart...
Key Metrics
Earnings dateMarch 1, 2027
P/E5.83
EPS-0.11
Book Value0.52
Price to Book0.63
Debt/Equity1.95
% Insiders74.095%
Growth
Revenue Growth-0.50%
Earnings Growth-0.44%
Estimates
Forward P/E1.37
Forward EPS0.24
Dividend
Dividend Yield12.12%
Annual dividends0.04 AUD
Ex-Div. DateNov. 23, 2025
Payout-16.96%

DCF valuation

Model fair value for EZZ Life Science Holdings Limited (EZZ.AX)
Result
Sign in to run the valuation for EZZ.AX.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

EZZ Life Science Holdings Limited Logo EZZ Life Science Holdings Limited Analysis (EZZ.AX)

Australia Consumer Staples Official Website Stock

Is EZZ Life Science Holdings Limited a good investment? EZZ Life Science Holdings Limited (EZZ.AX) is currently trading at 0.3100 AUD.

In terms of valuation, the stock trades at a P/E ratio of 5.83. This relatively low multiple may signal that EZZ Life Science Holdings Limited is undervalued compared to historical market norms.

Earnings Schedule: EZZ Life Science Holdings Limited is expected to release its next earnings report on March 1, 2027. The market consensus estimate for Forward EPS is 0.24.

For income investors, EZZ Life Science Holdings Limited pays a dividend yield of 12.12%. With a payout ratio of -17%, the dividend appears sustainable.

Investor FAQ

Does EZZ Life Science Holdings Limited pay a dividend?

Yes, it pays an annual dividend of 0.04 AUD (12.12% yield).

What asset class is EZZ Life Science Holdings Limited?

EZZ Life Science Holdings Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 1, 2027. The company currently has a trailing EPS of -0.11.

Company Profile

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, South-East Asia, and internationally. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

Exchange Ticker
ASX (Australia) EZZ.AX
Trades
Dividend Yield
12.12%
Annual Dividends
0.04AUD
Next Ex. Div Date
Nov. 23, 2025
Payout Ratio
-16.96%
Dividend History paid per year (AUD)
Historical Dividends
Year Total Dividends
▸2026
0.03 AUD
Dec. 16, 2026 (estimated) 0.0348
▸2025
0.04 AUD
Dec. 23, 2025 0.0200
June 17, 2025 0.0200
▸2024
0.04 AUD
Dec. 9, 2024 0.0200
June 17, 2024 0.0150
▸2023
0.02 AUD
Dec. 8, 2023 0.0100
June 23, 2023 0.0098
▸2022
0.00 AUD
Dec. 16, 2022 0.0045
▸2021
0.00 AUD
Dec. 16, 2021 0.0045
Upcoming Dividends
Name Payment Date Status Amount
EZZ Life Science Holdings Limited Dec 23, 2025 0.02 AUD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion